长达6个月的疗程可以成为全球MDR-TB的标准治疗方案吗?
Caterina Davoli1, Chiara Rossi1, Andrea Ciccarone1
1Clinic of Infectious and Tropical Diseases, Department of Clinical and Experimental, Sciences, University of Brescia, Brescia, Italy.
概括
针对多耐药结核病 (MDR-TB) 的新六个月治疗方案提供了更好的结果. BDLLfxC选项扩大了儿童和孕妇的治疗机会,但对于复杂的肺外MDR-TB病例仍然存在挑战.
科学领域:
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的抗药性结核病 (MDR-TB) 治疗时间长,耐受性差.
- 世界卫生组织推了两种新的6个月疗法:BPaLM和BDLLfxC.
- BDLLfxC为特定人群提供了替代方案,包括儿童和孕妇,在这些人群中,BPaLM不适合使用.
研究的目的:
- 在特定的患者群体中审查6个月MDR-TB疗程的应用.
- 确定与这些短期治疗相关的局限性和挑战.
- 评估针对MDR-TB管理的公共卫生方法取得的进展.
主要方法:
- 对当前文献和指导方针进行叙述性审查.
- 探索药理动力学/药理动力学方面的考虑.
- 对特定人群和复杂结核病形式的临床经验的分析.
主要成果:
- BDLLfxC疗法扩大了儿科,青少年和孕妇/哺乳期患者的治疗选择.
- 德拉曼尼德在BDLLfxC中取代了普雷托曼尼德,使其与BPaLM区别开来.
- 目前,由于潜在的疗效和缺乏数据,对于复杂的肺外MDR-TB (中枢神经系统,骨关节,扩散性疾病) 两种疗法都不推.
结论:
- 短期的MDR-TB疗法代表了治疗的重大进步.
- 对于复杂的肺外MDR-TB病例,需要进一步的研究和临床数据.
- 实现全面的公共卫生方法需要解决当前治疗方案的局限性.
相关概念视频
Pulmonary Tuberculosis V
543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543
Pulmonary Tuberculosis IV
479
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
479
Pulmonary Tuberculosis I
844
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
844
Pulmonary Tuberculosis III
941
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
941
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Dosage Regimens: Designs and Approaches
266
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
266


